Quick answers
- What is Cardizem LA?
- Cardizem LA is a brand name of Diltiazem, a prescription medicine. The FDA NDC Directory lists 6 Cardizem LA products in 6 strengths and forms.
- Who makes Cardizem LA?
- Bausch holds the FDA application for Cardizem LA (NDA021392, approved February 6, 2003).
- Is there a generic or store brand of Cardizem LA?
- Yes. The FDA NDC Directory lists 29 other products with the same active ingredients, strength and form as a Cardizem LA product, 29 of them generic. Ask your pharmacist whether one is right for you.
- Has Cardizem LA been recalled?
- No recall linked to Cardizem LA products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Cardizem LA is
Each Cardizem LA product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Diltiazem · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| diltiazem hydrochloride 120 mg tablet, extended release (oral) | Cardizem LA | 4 products, 4 companies | DailyMed |
| diltiazem hydrochloride 180 mg tablet, extended release (oral) | Cardizem LA | 5 products, 5 companies | DailyMed |
| diltiazem hydrochloride 240 mg tablet, extended release (oral) | Cardizem LA | 5 products, 5 companies | DailyMed |
| diltiazem hydrochloride 300 mg tablet, extended release (oral) | Cardizem LA | 5 products, 5 companies | DailyMed |
| diltiazem hydrochloride 360 mg tablet, extended release (oral) | Cardizem LA | 5 products, 5 companies | DailyMed |
| diltiazem hydrochloride 420 mg tablet, extended release (oral) | Cardizem LA | 5 products, 5 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Diltiazem →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA021392 | Bausch | February 6, 2003 | 6 |
Companies that list Cardizem LA
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Cardizem LA products.
- Bausch Health US LLC6 products
Recalls
No recall linked to Cardizem LA products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.